Fulcrum Therapeutics, Inc. · NASDAQ:FULC
Adage Capital Management, L.P. reported a 8.50% stake in Fulcrum Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 12, 2025
Adage Capital Management, L.P. reported a 8.50% stake in Fulcrum Therapeutics, Inc., 4,589,000 shares, as a passive investor on Jun 30, 2025. Filed Aug 12, 2025 (Schedule 13G/A).
- Stake
- 8.50%
- Shares
- 4,589,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 8.50% | 4,589,000 |
| Robert Atchinson | 8.50% | 4,589,000 |
| Phillip Gross | 8.50% | 4,589,000 |
Source
Related
- Fulcrum Therapeutics, Inc.
- Adage Capital Management, L.P.
- Fulcrum Therapeutics, Inc. shareholders
- Schedule 13G/A · Adage Capital Management, L.P. · Nov 13, 2025
- Schedule 13G · Adage Capital Management, L.P. · Feb 12, 2025
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Bank of America Corp · Aug 3, 2026